创科实业(00669)早盘上涨3.88%,现报103港元,成交额9737.90万港元。
消息面上,摩根大通发布研报称,美国市场在2024年上半年占其收入约75%,而创科的韧性关键在于其在远离中国供应链多元化方面的先行优势,以及可快速调整生产布局的营运弹性。
该行表示,相信凭借强劲的资产负债表和积极的供应链重组,公司比以往任何时候都更有能力应对这些挑战。鉴于上述情况,该行认为当前股价疲软是一个增持的机会,预期去年下半年公司利润同比升18%,同时自由现金流产生能力将增强,从而进一步降低资产负债表的杠杆率,该行予创科实业“增持”评级,目标价135港元。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.